By Matthias Berninger, SVP Public Affairs & Sustainability at Bayer
As I write this, the world holds its breath. The global COVID 19 pandemic, the coronavirus, affects many infected and worried people around the globe. Countless doctors, nurses and medical workers are tirelessly helping on the ground. Governments are on highest alert to control the situation, talking advice from scientific experts who are learning on the fly. Healthcare companies like Bayer are also in constant contact with authorities worldwide and provide support wherever possible.
Diversity and inclusion are part of our rich history and fundamental to our future success. In celebration of Black History Month, we highlight employees who have made an impact on our past, present and future.
Close your eyes and imagine a physicist. What does this person look like? Was it a white guy? Well, if it was, you might be guilty of reaffirming stereotypes, but you wouldn’t be wrong statistically speaking. According to the American Institute of Physics, less than 1% of American physicists are women of color. This week, we sit down with one such rarity: groundbreaking physicist Hattie Carwell.
From a donation of a million masks to help protect vulnerable healthcare workers to committed research on a potential vaccine, the company has activated quickly in several key ways to help address the outbreak.
Since 2011, Freeport-McMoRan’s Pollinator Conservation Initiative has sought to increase the habitat for pollinators and to provide learners of all ages with opportunities to engage with topics in Science, Technology, Engineering and Mathematics (STEM). Today, more than a dozen Freeport-McMoRan operations in North America have implemented pollinator conservation and education projects both on and off company property.
These programs have been recognized through the Wildlife Habitat Council’s (WHC) Conservation Certification program.
At Pfizer, we discover and develop novel vaccines that help protect people around the world from deadly viruses and bacteria. In 2018, we focused on rational vaccine design — understanding the structure of proteins enabled by high-tech tools like cryo-electron microscopy as a basis to design and produce those proteins for use in vaccines.
Written by Scott Heimlich, Vice President, Amgen Foundation
You know it when you see it.
Lin-Manuel Miranda transforming a book into something else entirely. Messi moving up the field with a soccer ball that moves along with him. Diamond taking 13,000 years of history – and multiple disciplines – to incredibly show us how and why societies advanced in different ways at different rates.
Mastercard, BanQu, Planet Labs sharing insights at SB’19 Detroit, June 3-6
SAN FRANCISCO, March 28, 2019 /3BL Media/ – Science and technology are just two of the many driving forces behind the environmental and social innovation needed to protect our planet and improve the lives of individuals. Advances in science and technology are creating opportunities for companies to rethink how they deliver value to their customers in support of new societal aspirations aligned with their views of the Good Life of today.
Today, Pfizer released the 2018 Annual Review highlighting the ways that patients are the driving force behind every aspect of the company’s business in its mission to deliver innovative medicines and vaccines that help improve health and well-being at every stage of life.
This year, the integrated report explores how Pfizer’s work keeps Patients at Our Center. Highlights include: